Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Seth Klarman, latest 13F

Seth Klarman · Q3 2017

Baupost Group

Portfolio at the end of Q3 2017, from the 13F filed November 13, 2017. See the filing on EDGAR ↗

CompanyWeightValueSharesPriceHeld sinceChange
Cheniere Energy LNG · history 11.6% $933.5M 20,726,340 $45.04 Q1 2014 No change
Synchrony SYF · history 11.3% $909.6M 29,295,030 $31.05 Q3 2016 No change
Viasat VSAT · history 10.5% $846.3M 13,158,137 $64.32 Q2 2013 or earlier No change
Qorvo QRVO · history 7.9% $636.1M 9,000,000 $70.68 Q1 2017 No change
Allergan AGN · history 7.6% $607.5M 2,964,203 $204.95 Q1 2016 Add 22%
Colony NorthStar CLNS · history 7.5% $601.7M 47,905,461 $12.56 Q1 2017 No change
Twenty-First Century Fox FOXA · history 6.3% $504.8M 19,137,469 $26.38 Q3 2015 No change
Antero Resources AR · history 5.9% $475.9M 23,912,257 $19.90 Q3 2014 Add 13%
PBF Energy PBF · history 5.4% $434.1M 15,724,175 $27.61 Q3 2013 No change
Theravance Biopharma TBPH · history 4.0% $318.7M 9,309,168 $34.24 Q2 2014 No change
Dell Technologies DELL · history 2.9% $235.7M 3,052,459 $77.21 Q3 2016 Reduce 46%
Twenty-First Century Fox FOX · history 2.4% $190.4M 7,384,542 $25.79 Q3 2015 Add 1%
Keryx Biopharmaceuticals KERX · history 2.3% $183.1M 25,791,678 $7.10 Q1 2014 No change
Cardinal Health CAH · history 2.1% $169.3M 2,530,000 $66.92 Q4 2016 Add 25%
Express Scripts ESRX · history 2.0% $161.9M 2,556,891 $63.32 Q1 2017 No change
Veritiv VRTV · history 1.2% $99.2M 3,053,724 $32.50 Q3 2014 No change
Atara Biotherapeutics ATRA · history 1.1% $88.7M 5,359,632 $16.55 Q4 2014 No change
McKesson MCK · history 1.0% $76.8M 500,000 $153.61 Q3 2017 Buy
Paratek Pharmaceuticals PRTK · history 0.7% $60.1M 2,394,498 $25.10 Q4 2014 No change
ChipMOS IMOS · history 0.7% $58.9M 3,048,295 $19.32 Q2 2013 or earlier Reduce 13%
AMC Entertainment AMC · history 0.7% $52.4M 3,565,361 $14.70 Q3 2017 Buy
GTY Technology GTYH.U · units · history 0.6% $46.0M 4,400,000 $10.46 Q4 2016 No change
Permian Resources CDEV · history 0.5% $42.1M 2,407,153 $17.48 Q4 2016 No change
Avis Budget Group CAR · history 0.5% $39.5M 1,036,900 $38.06 Q2 2017 Reduce 74%
Forward Pharma FWP · history 0.5% $39.2M 6,463,265 $6.07 Q4 2014 Add 2%
Novagold Resources NG · history 0.5% $39.1M 9,500,000 $4.12 Q2 2013 or earlier No change
Theravance Biopharma TBPH.CV · convertible notes · history 0.5% $37.1M 30,000,000 prn Q4 2016 No change
Cascadian Therapeutics CASC · history 0.4% $35.7M 8,721,079 $4.09 Q2 2016 No change
Saban Capital Acquisition SCAC · history 0.3% $23.4M 2,326,500 $10.05 Q4 2016 No change
Silver Run Acquisition II SRUN · history 0.3% $21.9M 2,149,352 $10.18 Q2 2017 Reduce 76%
Sunrun RUN · history 0.2% $15.8M 2,848,082 $5.55 Q3 2015 No change
Cencora COR · history 0.2% $15.6M 188,850 $82.75 Q3 2017 Buy
Trilogy Metals TMQ · history 0.1% $10.0M 10,600,758 $0.94 Q2 2013 or earlier No change
Orexigen Therapeutics OREX · history 0.1% $4.7M 2,226,839 $2.12 Q3 2015 No change
Pioneer Natural Resources PXD · history 0.1% $4.3M 28,895 $147.53 Q3 2017 Buy
Simply Good Foods SMPL.WS · warrants · history 0.0% $2.5M 1,035,146 $2.37 Q3 2017 Buy
Saban Capital Acquisition SCAC.WS · warrants · history 0.0% $1.4M 1,163,250 $1.18 Q4 2016 No change
37 positions100.0%$8.02B

Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q2 2017, adjusted for stock splits.

Sector weighting

Sector weights in this 13F
Energy23.6%
Health care22.4%
Media & telecom19.9%
Financials & real estate19.4%
Technology12.2%
Industrials1.4%
Materials0.6%
Other0.5%
Consumer staples0.0%

What changed from Q2 2017

← Q2 2017 Q4 2017 →